2-Morpholinomethyl-4'-trifluoromethylbenzophenone, 97.0%, 1g

4-Benzothiazol-2-yl-3-chloro-phenylamine, 98%, 1g

TERT-BUTYL 2,6-DIAZASPIRO[3.4]OCTANE-6-CARBOXYLATE HCL, 95.0%, 250mg

2,3,3-Trimethylindolenine, 95.0%, 500g

Methyl 3-bromo-4-ethoxybenzoate, 95.0%, 250mg

Benzo[d]isoxazole-5-sulfonyl chloride, 95.0%, 10g

Plan phase PLPHi 10x/0,25 objectif IOS corrigé à l'infini. Distance de travail 5,00 mm

(S)-2-((tert-Butoxycarbonyl)(ethyl)amino)propanoic acid, 98%, 1g

5-Chloro-6-methoxypicolinic acid, 95.0%, 1g

Furan-2,5-dicarbonitrile, 95.0%, 250mg

4-BROMO-1-CYCLOPROPYL-1H-BENZO[D]IMIDAZOLE, 95.0%, 5g

Flacon pulvérisateur, 50 ml, 5 pièce(s)

3-Bromo-5-nitropyridin-4-ol, 95.0%, 25g